Vinay, I’d be interested on your take at some point on pharma’s push for coverage of expensive somatic gene therapies to treat sickle cell disease vs the relative lack of insurance coverage/funding for IVF/PGT which would prevent most cases of SCD to begin with.
Vinay, I’d be interested on your take at some point on pharma’s push for coverage of expensive somatic gene therapies to treat sickle cell disease vs the relative lack of insurance coverage/funding for IVF/PGT which would prevent most cases of SCD to begin with.